Alternus Secures First Investment Tax Credit under the IRA to Finance Solar Projects

Stock Information for Cyclacel Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cyclacel Pharmaceuticals Inc.

Alternus Clean Energy to Participate at The Microcap Conference 2025 Alongside Top Growth Companies
Alternus Clean Energy Announces Closing of $2.25 Million Private Placement
Alternus Clean Energy CEO Vincent Browne Highlights Milestones and Growth Vision for 2025 on Proactiveinvestors.com
Alternus Clean Energy Secures Full Permitting for First of Its Eleven Italian Solar Projects; Construction is Expected to Start in Q2 2025
Alternus Clean Energy Completes Acquisition of LiiON, a Leading US-Based Provider of Advanced Energy Storage Solutions
Alternus Clean Energy Announces Binding Terms for Acquisition of Leading Storage and Solution Provider LiiON, LLC
Alternus Clean Energy Continues Deleveraging Program by Removing Additional $30 Million of Debt, Improving Shareholder Equity by Approximately $4 Million
Alternus Clean Energy, Inc. Announces 1-for-25 Reverse Stock Split as Part of Nasdaq Compliance Plan

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.